Sanofi
SNY
480 hedge funds and large institutions have $7.94B invested in Sanofi in 2018 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 104 increasing their positions, 201 reducing their positions, and 59 closing their positions.
674% more call options, than puts
Call options by funds: $69.4M | Put options by funds: $8.96M
40% more funds holding in top 10
Funds holding in top 10: 10 → 14 (+4)
7% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 59
4% more capital invested
Capital invested by funds: $7.61B → $7.94B (+$335M)
0% more funds holding
Funds holding: 478 → 480 (+2)
0.99% less ownership
Funds ownership: 15.15% → 14.16% (-0.99%)
48% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 201
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$40.8M |
| 2 |
TA
Teachers Advisors
New York
|
+$30.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.4M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$24.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$148M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$103M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$76.3M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$71.9M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$40.5M |
SNY Hedge Fund Activity: Q3 2018 in Review
480 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2018, worth a combined $7.94B — up 4.4% from $7.61B a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new SNY positions and 59 closed out — a net gain of 4 holders — while 104 added to existing stakes and 201 trimmed.
The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $40.8M. The largest seller was Berkshire Hathaway, exiting entirely with an estimated $148M sold.
- 480 institutional investors held Sanofi (SNY) as of Q3 2018, up from 478 in Q2 2018.
- Funds reported $7.94B of Sanofi stock for Q3 2018, up 4.4% quarter-over-quarter.
- 63 funds opened new Sanofi positions in Q3 2018 and 59 closed out, a net change of +4 holders.
- The largest Sanofi buyer in Q3 2018 was Barrow, Hanley, Mewhinney & Strauss, an estimated $40.8M added.
- The largest Sanofi seller in Q3 2018 was Berkshire Hathaway, an estimated $148M sold.
Based on aggregated 13F filings for Q3 2018.